行情

CLSD

CLSD

Clearside
NASDAQ

实时行情|Nasdaq Last Sale

0.7342
-0.0079
-1.06%
休市 16:00 09/20 EDT
开盘
0.7440
昨收
0.7421
最高
0.7699
最低
0.7110
成交量
16.45万
成交额
--
52周最高
6.62
52周最低
0.5600
市值
2,772.32万
市盈率(TTM)
-0.3627
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CLSD 新闻

  • 全球阻击电子烟
  • 新浪财经综合.1小时前
  • 欧洲最大骗税案开审 "掠夺欧洲的男人"出庭披露内幕
  • 新京报.1小时前
  • 2025年或推出AR眼镜 Facebook能否扭转行业颓势?
  • 新浪财经-自媒体综合.2小时前
  • 据悉任天堂千方百计将Switch Lite售价压低至200美元
  • 新浪财经综合.3小时前

更多

所属板块

生物技术和医学研究
+0.62%
制药与医学研究
+0.95%

热门股票

名称
价格
涨跌幅

CLSD 简况

Clearside Biomedical, Inc. is a clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Company's product candidates focus on diseases affecting three components of the eye: the retina, which is the tissue that lines the inside of the eye and is primarily responsible for vision; the choroid, which is the layer adjacent to the retina that supplies the retina with blood, oxygen and nourishment, and the sclera, which is the outer protective layer of the eye. The Company’s lead product candidate, XIPERE, is a proprietary, preservative-free suspension of the corticosteroid triamcinolone acetonide formulated for administration via suprachoroidal injection.
展开

Webull提供Clearside Biomedical Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。